Gerhard Dickneite
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Tissue distribution of rIX-FP after intravenous application to rodents.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 27, 2020
Evaluation of urinary biomarkers for early detection of acute kidney injury in a rat nephropathy model.
Journal: Journal of pharmacological and toxicological methods
Published: January 16, 2020
Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animals.
Journal: Pharmacology research & perspectives
Published: November 02, 2015
FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
Journal: British journal of haematology
Published: October 01, 2015
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 17, 2015
Local activation of coagulation factor XIII reduces systemic complications and improves the survival of mice after Streptococcus pyogenes M1 skin infection.
Journal: International journal of medical microbiology : IJMM
Published: May 29, 2015
Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: March 14, 2015
Effective reversal of edoxaban-associated bleeding with four-factor prothrombin complex concentrate in a rabbit model of acute hemorrhage.
Journal: Anesthesiology
Published: November 25, 2014
Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
Journal: Clinics in laboratory medicine
Published: August 30, 2014
Last Updated: 09/26/2026